PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of agpsychBioMed Centralbiomed central web sitesearchsubmit a manuscriptregisterthis articleAnnals of General Psychiatry
 
Ann Gen Psychiatry. 2010; 9(Suppl 1): S34.
Published online 2010 April 22. doi:  10.1186/1744-859X-9-S1-S34
PMCID: PMC2991945

Metabolic alterations in patients with depression and their relationship to the etiology of depressive disorders

Major depressive disorder (MDD) is an independent risk factor for the development of type 2 diabetes (T2DM) and cardiovascular disorders (CVD). Vice versa, patients suffering from T2DM or CVD bear an elevated risk of developing MDD. Recent epidemiologic studies suggest that MDD promotes the development of the metabolic syndrome (MetS), a well known risk factor for the development of T2DM and CVD. Furthermore, patients at risk for type 2 diabetes have a higher incidence of the MetS after a lifetime episode of MDD. These results point to an important role of MDD in the development of T2DM and CVD, and a bidirectional modulation between MDD and T2DM/CVD. Several risk factors for the above mentioned associations have been described. Among these, a dysregulation of endocrine and immune systems, sedentary lifestyle and adverse health related behaviors have been found. Recently, a dysregulation of the central energy metabolism has been proposed as superordinated hypothesis to explain metabolic abnormalities in the context of depression. These findings expand our understanding of MDD as a complex, multi-etiological and multi-system disorder. As suggested by the joint recommendations of the EPA, EASD and ESC on diabetes and cardiovascular risk in patients with severe mental disorders, increased awareness of metabolic disorders is necessary in patients with depressive disorders.


Articles from Annals of General Psychiatry are provided here courtesy of BioMed Central